To investigate the full range of molecular changes associated with erectile dysfunction (ED) in type 1 diabetes, we examined alterations in penile gene expression in streptozotocin-induced diabetic rats and littermate controls. Using Affymetrix GeneChip arrays and statistical filtering, 529 genes/transcripts were considered to be differentially expressed in the diabetic rat cavernosum as compared to control. Gene Ontology (GO) classification indicated that there was a decrease in numerous extracellular matrix genes (e.g., collagen and elastin related) and an increase in oxidativestress genes in the diabetic rat cavernosum. In addition, PubMatrix literature mining identified differentially expressed genes previously shown to mediate vascular dysfunction (e.g., Cp, Lpl, Cd36) as well as genes involved in modulation of smooth muscle phenotype (e.g., Klf5, Cx3cl1).
Introduction
Erectile dysfunction (ED) has origins associated with a complex interplay of factors ranging from psychosocial disorders (e.g., depression) to nerve injury (e.g., prostatectomy) to vascular pathologies (e.g., hypertension, atherosclerosis). Of all co-morbid medical conditions, diabetes mellitus imparts the greatest risk of ED. Men with diabetes have a greater prevalence of ED and earlier onset of the condition as compared to the general population (34, 101) . Furthermore, men with diabetes present with more severe dysfunction and are less responsive to current pharmacological therapies for ED (14, 47, 91) .
Penile erection is a complex and integrated neurovascular event (4) . Since diabetes leads to neural and vascular pathologies, it has the potential to impact all components of the erectile response. Structurally, the erectile apparatus consists of paired organs (corpora cavernosa) that run the length of the penis. Each cavernosum is a specialized vascular compartment with sinusoidal trabeculae supporting a thick smooth muscle layer lined by endothelial cells. The arterial supply of the penis gives rise to helicine resistance arteries which open directly into the sinusoidal spaces of the cavernosa (108) . During erection, nitric oxide (NO) produced by nitrergic nerves (autonomic neurons containing neuronal NO synthase; nNOS) and endothelial cells (endothelial NO synthase; eNOS) stimulates relaxation of smooth muscle in the penile circulation and corpora cavernosa (108) .
In the smooth muscle cells, NO binds soluble guanylate cyclase thus increasing cGMP levels and stimulating cGMP-dependent protein kinase I (Prkg1 alias cGKI) which ultimately leads to relaxation (49) . The ensuing arterial inflow and expansion of the cavernosa against the tunica albuginea (dense connective tissue surrounding the cavernosa) leads to compression of subtunical veins that impede blood outflow, producing a rigid erection.
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Although recent studies have been instrumental in establishing mechanisms of impaired diabetic erectile function (see recent reviews [7, 11] ), it is likely that the molecules and pathways identified to date represent only a small portion of the total changes occurring in erectile tissues that are due to diabetes. Thus, the current study was designed to take a global approach to investigate the range of molecular changes in cavernosal tissue from animals with diabetes-associated ED. The ultimate goal is to advance our understanding of the pathogenesis of diabetes-associated ED and to help provide a rationale for novel treatments and preventive therapies.
Methods

Animals and induction of diabetes.
Male Fischer 344 rats (Taconic Farms) were housed in groups of 2-3 in a specific pathogen-free environment. Rats were maintained in a temperature-controlled room with 12:12h light dark cycle and received food and water ad libitum. All procedures were approved by the Animal Care and Use Committee at the University of Washington and were performed in accordance with NIH Guidelines for the Care and Use of Animals. At 2 months of age, rats were separated into individual cages and injected intraperitoneally with 35 mg streptozotocin (STZ; Sigma Chemical) per kg body weight in sterile citrate buffer to induce diabetes. Control rats were injected with an equivalent volume of citrate buffer. Twenty-four hr after injections, blood glucose was checked via tail stick using an Accu-Check glucose monitor (Roche Diagnostics). Animals were considered diabetic if their blood glucose levels were above 300 mg/dL. Body weight and glucose levels were monitored weekly in all animals over the course of the study (10 weeks). Ten-weeks duration of diabetes was selected based on previous studies demonstrated significantly reduced erectile responses in Fischer 344 rats following 8-12 weeks of diabetes (26, 98) . Values are
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presented as the mean ± SE. Comparison between two means was performed using Student's unpaired t-test.
Measurement of erectile responses. Ten weeks after induction of diabetes, intracavernosal pressure (ICP) changes in response to cavernous nerve stimulation were measured in control (n=8) and diabetic rats (n=6) as described previously (125) . Briefly, anesthesia was induced with 5% isoflurane (Novaplus) vaporized in 100% O 2 and then maintained with 1.5% isoflurane during the procedures.
The right carotid artery was cannulated to monitor arterial blood pressure. The penis was exposed and the corpus spongiosum was mobilized to facilitate insertion of a 25-gauge needle into the corpus cavernosum. The needle was attached via PE-50 tubing to a pressure transducer (Kent Scientific) filled with heparinized saline. To establish baseline parameters, the cavernous nerve was stimulated (6 V, 10 Hz, 1 min) with a bipolar electrode, Grass S48K nerve stimulator, and stimulus isolation unit SIU5 (Grass Telefactor). Pressure changes were recorded continuously in response to 1, 2, 4, 6, and 10 V stimulations, each for a duration of 1 min with 5 min between voltages. Intracavernous and arterial pressure were converted to analog signals and transmitted to a data acquisition program (Hem 3.2, Notocord). The erectile response was calculated using area under the curve in mmHg for intracavernosal pressure during the 1 min stimulation period (∆ICP). This value was divided by the area under the curve for the calculated mean arterial pressure (MAP) during the same 1 min stimulation (∆ICP/MAP). Groups were compared by one-way ANOVA with a Student-NewmanKeuls multiple comparison test.
Tissue Collection. Immediately following ICP measurements, the penis was rapidly dissected free at the level of the crura. After removal of any overlying skeletal muscle, equal portions of the crura and
shaft were placed into1.5 ml tubes, flash frozen in liquid nitrogen, and then stored at -80°C. For histology, a small cross-section of the proximal shaft was suspended in OCT compound (TissueTek), frozen over liquid nitrogen, and stored at -80°C. An independent cohort of control and diabetic F344 rats (n=5 each) was generated and used to collect penile protein samples for Western blotting.
The samples were collected as described above and stored at -80°C.
RNA isolation. Total RNA isolation was performed using a combination of Trizol Reagent (Invitrogen) and RNeasy columns (Qiagen). Penile tissue stored at -80°C was gradually thawed using RNAlater-ICE (Ambion) as described by the manufacturer. Next, tissue was homogenized in Trizol Reagent according to the manufacturer's instructions with the following modifications. After addition of chloroform, the centrifugation was performed using Phase Lock Gel Heavy 2 ml tubes (Eppendorf) to improve recovery of the aqueous phase of the solution. One half volume of 100% ethanol was combined with the recovered aqueous solution and the mixture was added to an RNeasy mini column. This and all subsequent steps were performed as described by the manufacturer (Qiagen RNeasy handbook 3 rd edition). On-column DNase digestion was done using the Qiagen RNase-Free DNase kit as directed in the RNeasy handbook (appendix D). RNA quality was examined by the RNA 6000 LabChip Kit on the 2100 bioanalyzer (Agilent Technologies). Quantity and absorbance at 260/280 nm of total and cRNA was assessed by UV spectrophotometer. After quantification RNA samples were divided into 5 µg aliquots and stored at -80°C.
Microarray hybridization and data analysis. Double-stranded cDNA was synthesized from total RNA, amplified as cRNA, labeled with biotin, and hybridized to Affymetrix Rat 230A GeneChips, which were washed and scanned at the University of Washington's Center for Expression Arrays according to procedures developed by the manufacturer. A total of 5 control and 5 diabetic samples were used requiring a total of 10 GeneChips. Image processing was done using Affymetrix GCOS software. The quality of hybridization and overall chip performance was determined by visual inspection of the raw scanned data and the GCOS generated report file. The raw data were loaded into the Rosetta Resolver Gene Expression Data Analysis System (Rosetta Biosoftware, Seattle, WA) for analysis utilizing the Rosetta Resolver System error model (97 Real-time PCR. Using the samples from the array experiments (n=5 each group), 2 µg of total RNA was reverse transcribed into cDNA using RETROscript first strand synthesis kit (Ambion). Each
cDNA sample was then used as a template for real-time PCR amplification using SYBR Green PCR Master Mix (Applied Biosystems) and forward/reverse primers for the various target genes (see online supplement for primer sequences). Amplification and detection was performed on an Applied
Biosystems 7900 Real-Time PCR system according to manufacturer's instructions using a two-stage cycle of 95°C for 15 sec and 62°C for 1 min repeated for 40 cycles followed by a dissociation stage.
Threshold cycle (C T ) values were exported into spreadsheets and then relative changes in gene expression were calculated using the 2 -∆∆CT method as described previously (73) . Results are given as fold change relative to control (non-diabetic) cDNA while using Actb (Beta actin) expression as a reference gene. All samples were prepared and examined in parallel. Conventional, non-quantitative PCR was performed for ceruloplasmin (Cp) to confirm the presence of its two splice variants based on published primer sets (20, 89) . A common forward primer was used for both splice variants of Cp, 5'-GTA TGT GAT GGC TAT GGG CAA TGA-3'. The Cp-serum or secreted form was detected using the reverse primer 5'-TCA TCT GTC CAT CGG CAT TA-3', which yields a product size of 374bp. The Cp-GPI or glycosylphosphatidylinositol anchored form was detected using the reverse primer 5'-CCT GGA TGG AAC TGG TGA TGG A-3'and yields a product size of 449bp. 
Results
Glucose levels in diabetic rats. Mean body weight of diabetic rats at week 10 was significantly lower than control (245 ± 8 vs. 377 ± 13 g, respectively, p < 0.01). Blood glucose was significantly higher in diabetic rats relative to control (386 ± 8 vs. 94 ± 5 mg/dL, respectively, p < 0.0001) and glucose levels in the STZ group were maintained at 300 mg/dL or above throughout the course of the study. Examples of the raw ICP and arterial pressure tracings for a representative diabetic and control
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animal are shown in Figure I of the online supplement. Maximum ICP/MAP was also significantly lower in diabetic rats vs. controls (data not shown).
Array analysis and strategies to determine biological significance. Statistical filtering of the array analysis was based on at least a 1.5 fold change in expression and a Resolver ANOVA p ≤ 0.01. This p-value cutoff was estimated to be equivalent to a false discovery rate of 0.10 (q-value) or 10% using the methods of Storey and Tibshirani (110) . Genes with detection p-values of greater than 0.01 in both groups were considered not present and were excluded from further analysis. Based on these criteria, 529 genes were considered to be differentially expressed in the diabetic cavernosum (206 upregulated and 323 downregulated). Rosetta Resolver generated values including fold change and p-values for the 529 selected genes are available online (supplement) and Affymetrix data files have been submitted to the NCBI Gene Expression Omnibus.
Various strategies were used to examine the 529 changed genes (~350 were annotated genes or homologs) to determine their possible biological relevance to diabetes-associated ED. In particular, the Gene Ontology tool GoMiner was utilized to categorize genes according to biological process, molecular function, and subcellular localization (130) . Based on GoMiner analysis, there was significant enrichment of downregulated genes in GO categories such as (# genes down in diabetes per GO catergory / # genes in category on GeneChip): extracellular matrix (ECM) structural constituent (11/39), fibrillar collagen (7/9), ECM structural constituent conferring tensile strength and GO terms) is available in the online supplement. Table 1 shows groupings of genes based on similar Gene Ontology and functional categorization. Many genes are represented by more than one Affymetrix probe set on the RAE230A GeneChip, and in many cases multiple probe sets for the same gene were found to be significant (e.g., Cspg2, Lox, and others as shown in Table 1 ). The functional grouping of the differentially expressed transcripts shows several elastic fiber-related genes that were downregulated in the diabetic cavernosum (e.g., Cspg2, Lox, Fbn1, and Eln).
Similarly, genes encoding a total of 8 different collagen family members were downregulated in the diabetic samples. Various other ECM-related genes were differentially expressed in the diabetic cavernosum, including genes (Spp1, Tnc, and Sparc) that encode members of the functionally grouped matricellular proteins (Table 1) .
Using a web-based tool (PubMatrix) for literature mining of PubMed (8) lipoprotein lipase (Lpl), and Cd36. Alternatively, sorting for citations related to smooth muscle and blood vessels helped to identify numerous differentially expressed genes with potential function in vascular SMC biology, such as Klf5, Cx3cl1, S100a4, C3, Sparc, and Spp1.
Real-time PCR confirmation of array results. We used real-time PCR to examine expression for 23 genes shown to be significantly different by array analysis. These genes were selected based on fold change in expression, GO results, and/or potential role in diabetic complications or vascular biology as identified via PubMatrix. Table 2 shows the fold change estimated by Resolver for the GeneChip data compared to the fold change determined using real-time PCR. The majority of genes showed similar changes in expression when comparing the two methods. One exception is elastase-2 (Ela2) which showed no difference between groups by real-time PCR but had an estimated 4. 
Discussion
The present analysis provides a global view of the effect of diabetes on erectile tissue at the mRNA level. This is the first study to use microarrays to examine gene expression in cavernosal tissue from animals with diabetes-associated ED. The identification of approximately 500 differentially expressed genes/transcripts in the diabetic samples underscores the complex nature of this condition and supports the notion that diabetes causes multiple pathophysiological changes in erectile structures of the penis. Determining biological relevance of so many altered genes poses a tremendous challenge. We used several strategies for biological interpretation of our results such as Gene Ontology analysis and mining of the NCBI literature. It is not surprising in diabetes that a large portion of the significantly upregulated genes are involved in pathways required for lipid metabolism. A number of the differentially expressed genes have been previously associated with diabetic complications in other organ systems (see Table 2 for a few examples). This suggests the existence of common molecular pathways underlying the development of diabetic complications in Elastic fibers, composed of microfibrillar bundles with an inner core of crosslinked elastin, provide tissues such as the corpora cavernosa with resilience and deformability that allow repeated cycles of expansion and recoil. The array analysis revealed significantly reduced expression of several genes encoding microfibril and elastic fiber-associated molecules in the diabetic cavernosum (Table 1 ). The genes for elastin (Eln) and fibrillin1 (Fbn1) were modestly downregulated. Fibrillin protein is a principal component of the elastin-associated microfibrillar bundles (see recent review [62] ). Diabetes was associated with decreased Mfap2 (microfibrillar-associated protein2) and Bgn (biglycan) gene expression. Mfap2 encodes a protein that may be important in microfibril structural integrity, whereas biglycan protein can form a complex with both MFAP2 and elastin molecules (62) . Chondroitin sulfate proteoglycan2 (Cspg2; alias versican), with 2 to 3-fold reduced gene expression in diabetic samples, binds fibrillin molecules and may act to link elastin-associated microfibrils with surrounding ECM components in tissue (55) . Interestingly, Cspg2 overexpression in cultured aortic SMCs increased elastin mRNA levels and induced elastic fiber formation (79).
Merrilees and colleagues also showed that Cspg2 overexpression promotes elastic fiber deposition in balloon-injured rat carotid arteries (79).
The observed decline in diabetic gene expression of lysyl oxidase (Lox) is noteworthy considering Lox encodes an enzyme required for proper crosslinking of elastin and collagen in vascular tissue (50, 75) . LOX crosslinking activity mediates stabilization of collagen and elastin fibers in the ECM and also helps deposit elastin onto microfibrils (58) . In fact, arteries of Lox Previous studies evaluating human cavernosal structures show reduced elastic fibers in samples from impotent versus potent patients and diabetic versus non-diabetic patients (105, 128) .
Similar evaluations of elastic fibers in erectile tissue using animal models of diabetes have not been
reported. Salama and colleagues (102) describe thickening of collagen bundles in the diabetic rat tunica albuginea and altered collagen architecture, but changes in elastic fibers were not addressed.
Interestingly, the tunica albuginea of aged rats shows structural alterations including thinning and fragmentation of elastic fibers (15) . These observations are consistent with studies of the vasculature showing that diabetes is associated with reduced elasticity of coronary arteries and decreased elastin levels in the aorta (68, 112) .
Another notable finding is the reduced expression of Sparc (alias osteonectin), Spp1 (alias osteopontin), and Tnc (tenascin C) in the cavernosum of diabetic rats. Each of these genes encodes a member of the matricellular family of proteins. Matricellular proteins are unique ECM molecules that do not appear to have direct structural roles, but instead mediate cell-matrix interaction and cell function. For instance, Spp1 and Sparc are reported to influence diverse biological processes including vascular function and structure (refer to Table 2 ). Carotid arteries of Spp1 knockout mice exhibit loosely organized collagen fibers and vessels have increased compliance (81) . Similarly,
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matrix disorganization and smaller diameter collagen fibrils are observed in the healing wounds of Spp1 knockouts (71) . Sparc knockout mice also have phenotypes involving alterations in ECM organization and structure. For example, collagen fibers surrounding tumors grown in Sparc knockouts have reduced fiber diameter and attenuated fiber crosslinking (13) . The dermis of mice lacking Sparc has decreased collagen fibril size and altered collagen composition, suggesting the presence of immature collagen fibers (12) . It remains to be determined whether reduced matricellular protein expression in the diabetic cavernosum is causing alterations in ECM production and/or assembly.
Ceruloplasmin upregulation in the diabetic cavernosum. As explained in the results, we used
PubMatrix searches of the differentially expressed genes to help identify molecules that might influence erectile responses by altering vascular function. Ceruloplasmin is an example of one such molecule previously shown to affect vascular responses. CP is a multifunctional protein, initially isolated from plasma, which has numerous proposed biological functions including copper transport, iron metabolism, and substrate oxidation and reduction (10) . Alternative splicing of the Cp gene yields two distinct mRNA sequences that encode GPI-linked (membrane anchored) and secreted forms of CP, both of which were upregulated in the diabetic cavernosum based on real-time PCR (89) . This is consistent with a recent study showing increased Cp gene expression (3.1-fold, Affymetrix data) and elevated CP protein (1.7-fold) in retinal cells from STZ-treated rats (42) .
Previous studies report increased serum CP levels in patients with type 1 or type 2 diabetes (22, 23).
Cp is expressed in numerous tissues including liver, testis, lung, brain, placenta, and eye (3, 65 
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protein expression in our samples. Previous examinations of liver and lung tissue showed lack of Cp mRNA in the vascular endothelium, making it unlikely that cavernosal endothelial cells are a source of CP (65) . However, liver endothelial cells are able to bind and internalize CP from the serum, possibly through interaction with a membrane receptor (59, 115) . Therefore, CP localized to the cavernosal endothelium (Figure 3c and 3e) could be from the binding of CP produced locally (e.g., SMCs) and/or secreted by the liver (i.e., circulating in blood). The 16-fold upregulation of Cp-serum mRNA in diabetic samples seems to suggest that CP secretion may be enhanced locally within the erectile tissues. The Cp-GPI splice variant was also upregulated by diabetes (2.4 fold); based on mRNA abundance, this variant appears to be the principal form of Cp mRNA normally expressed in the cavernosum. Interestingly, GPI-anchored proteins exhibit cell to cell transfer in certain experimental conditions (67) . Regardless of the source or form, higher amounts of CP protein were detected in the penile tissues of diabetic rats and the most prominent CP staining was localized to the cavernosal SMCs and endothelium.
In terms of vascular function, CP at physiological levels impairs endothelial-dependent relaxation of the aorta in a dose-dependent manner (17) . This reduced vascular reactivity appears to be due to the ability of CP to decrease endothelial-dependent nitric oxide production via inhibition of eNOS (9) . These activities may be related to enhanced copper (Cu SMCs and endothelial cells (6, 80, 86, 131) . Ox-LDL can impair both vascular and cavernosal relaxation, while glycated-LDL has been shown to induce endothelial cell apoptosis and reduce eNOS expression (1, 5, 107) . These studies present multiple mechanisms by which cavernosal upregulation of Lpl could contribute to ED.
Cd36 expression. The 2-fold upregulation of Cd36 gene expression in the diabetic cavernosum is consistent with previous studies demonstrating increased CD36 in the heart of diabetic mice and tissues from diabetic rats (45, 90) . Interestingly, macrophage Cd36 gene expression is increased by glucose and atherosclerotic lesions from patients with hyperglycemia have greater CD36 levels (46) . CD36 (also termed fatty acid translocase) is a type B scavenger receptor that binds to collagen, thrombospondin, anionic phospholipids, and ox-LDL (see review [82] ). CD36 is expressed by a variety of cell types including cardiac myocytes, skeletal myocytes, microvessel endothelial cells, and cultured aortic smooth muscle cells (45, 60, 99, 113) .
Immunostaining for CD36 in diabetic and control rat cavernosum showed strongest staining in capillaries and microvessels surrounding and within the erectile tissues, as well as discontinuous staining of the cavernosal sinusoids (online supplement, Figure III protein levels increased progressively in the vessel media and neointima following carotid injury in rats (38). The role of Klf15 in SMC biology has not been studied and so the significance of its
upregulation in the diabetic cavernosum is unknown. Klf15 expression is present in all muscle lineages, including SMCs of the vasculature (44) .
In relation to SMC phenotype, it is important to point out that we did not detect diabetesassociated changes in several SMC differentiation marker genes (e.g., Acta2-SMA α-actin; Myh11-SM myosin heavy chain; Cnn1-Calponin1; and Smtn-Smoothelin). This would seem to contradict the presence of profound or widespread dedifferentiation of SMCs in the diabetic cavernosum.
However, previous array analysis of vascular neointima formation-characterized by SMC phenotypic modulation and proliferation-did not demonstrate wholesale changes in the above mentioned SMC markers (39). Also, we cannot rule out changes in expression of the various SMC genes at times other than our 10 week end-point or that alterations were present at the protein but not the mRNA level.
Based on literature mining, we were able to identify additional genes that could be affecting SMC biology in the diabetic rat penis. For example, diabetic upregulation of C3 (complement component3; 2-fold increase, p = 0.00345) may alter cavernosal SMC tone given that C3 is able to cause constriction of isolated arteries (77) . C3 expression was detected selectively in the aorta and cultured SMCs from spontaneously hypertensive rats (72) . Further, exogenous C3 protein caused dedifferentiation of SMCs and shifted gene expression towards a synthetic SMC phenotype (72) .
Another upregulated gene in the diabetic cavernosum, Cx3cl1 (chemokine C-X3-C motif ligand1; alias fractalkine) encodes a protein that is able to increase SMC adhesion and proliferation in an autocrine fashion in response to inflammatory cytokines (18) . Cx3cl1 mRNA and protein are upregulated in diabetic rat kidneys as well as in atherosclerotic arteries from patients with and without diabetes (63, 127) . Finally, we detected significantly reduced gene expression for S100a4
(alias metastasin and calvasculin), which encodes a member of the S100 family of Ca2 + -binding
proteins. S100a4 has been implicated in various cellular processes and appears to be constitutively expressed in the aorta and cultured SMCs (24). Cellular localization of S100A4 protein in SMCs and vascular tissue shows S100A4 to be strongly associated with actin stress fibers and with the sarcoplasmic reticulum (76) . In addition to interacting with intracellular proteins, S100A4 may have extracellular function as a secreted protein (124) .
The potential for phenotypic modulation of the diabetic cavernosal smooth muscle is an intriguing idea that has yet to be established. Changes in any number of the above genes may be indicative of an altered differentiation/maturation state in the SMCs of the cavernosum and penile vasculature which would have important implications on erectile function. Phenotypic modulation may well reflect changes in the assortment of necessary contractile proteins, signaling molecules, growth factors, and matrix modulators of properly functioning cavernosal SMCs.
Limitations. Expression analysis with microarrays can be a valuable and powerful technique, but certain limitations exist in the present study that merit discussion. Although erectile tissues are relatively SMC-enriched, there is clearly a mixture of cell types in the harvested cavernosal samples.
As a result, all the various cell types potentially contribute to the differential gene expression detected in this analysis. With the exception of certain cell-type specific genes, further characterization will be required to identify a particular source of altered gene expression.
Additionally, our analysis merely establishes an association between the observed gene changes and diabetic ED. Further experimentation is necessary to distinguish between differentially expressed genes that are actual mediators of ED, markers of ED, or inconsequential to ED. This is an expected challenge often present in microarray studies and so our analysis should be primarily viewed as hypothesis generating. Also, the Affymetrix RAE 230A GeneChips contain probe sets representing over 15,000 genes and transcripts including the majority of full-length, well-annotated rat genes.
However, the 230A GeneChip does not contain probe sets for all rat genes and as a result this analysis is incomplete. Furthermore, evaluation of gene expression at a single time point may miss critical changes that occur earlier or later in the progression of ED. A more comprehensive analysis of temporal changes, based on patterns of expression over time, would also be helpful in delineating those genes that might directly lead to ED. However, the high costs of evaluating large-scale gene expression (e.g., GeneChips) restricted the design of our current study. Related to this, we were not able to examine gene expression patterns from multiple organs or tissues which may be a useful strategy to differentiate between global versus tissue-specific expression changes in response to diabetes. By surveying expression patterns across several tissues, Knoll and colleagues to were able to identify common and tissue-specific transcriptional changes in response to short-term diabetes in rats (66) . Finally, while Gene Ontology analysis is reasonably objective in design, we acknowledge that literature mining as it was used here is a rather subjective method to identify genes of interest.
Nevertheless, PubMatrix was a useful tool to generate a vascular-focused and disease-relevant annotation of our microarray data. We think that such an approach is appropriate given the vascular nature of erectile tissue and the physiology of penile erection. The availability of the raw Affymetrix files in the GEO repository will allow other researchers to apply different data-mining strategies and analysis techniques to our data. Also, future analysis combining data sets from other research groups using microarrays to study erectile dysfunction may be useful to identify common mechanisms present in the different animal models of ED (119) .
Summary. This study expands the scope of potential candidate genes and pathways that are dysregulated by diabetes and that could negatively impact erectile function. Based on Gene Ontology classification, there was an enrichment of dysregulated extracellular matrix genes (e.g., collagen and elastin related) that may have important functions related to cavernosal structure (e.g.,
lysyl oxidase). Also, we have focused on the discovery of novel gene changes that may affect the proper function of vascular cells in the penis (e.g., ceruloplasmin) and therefore contribute the development of ED. The various genes and molecules that have been identified in our study can be further evaluated as possible diagnostic tools (e.g., biomarkers) or potential drug targets in patients with diabetes-associated ED.
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